{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:04:29Z","timestamp":1779858269781,"version":"3.53.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Project Supported by Science Foundation of Kangda College of Nanjing Medical University","award":["KD2024KYJJ036, KD2024KYJJ038, KD2024KYJJ040, KD2024KYJJ044, KD2023KYJJ054"],"award-info":[{"award-number":["KD2024KYJJ036, KD2024KYJJ038, KD2024KYJJ040, KD2024KYJJ044, KD2023KYJJ054"]}]},{"name":"the 2024 Lianyungang City Tumor Prevention and Treatment Science and Technology Development Plan Project","award":["ZD202403, QN202412, QN202416, QN202418"],"award-info":[{"award-number":["ZD202403, QN202412, QN202416, QN202418"]}]},{"name":"the Bengbu Medical University Key Natural Science Project","award":["2024byzd300, 2024byzd303, 2024byzd307"],"award-info":[{"award-number":["2024byzd300, 2024byzd303, 2024byzd307"]}]},{"name":"iangsu Provincial Health and Health Commission Research Project","award":["K2024084, JSZJ20241204"],"award-info":[{"award-number":["K2024084, JSZJ20241204"]}]},{"name":"the Lianyungang City 521 High-level Talent Training Project","award":["LYG065212024074"],"award-info":[{"award-number":["LYG065212024074"]}]},{"name":"the Lianyungang City Health Science and Technology Project","award":["202321"],"award-info":[{"award-number":["202321"]}]},{"name":"the Anti-Cancer Association Lianyungang City Tumor Prevention and Treatment Project","award":["ZD202305"],"award-info":[{"award-number":["ZD202305"]}]},{"name":"the Jiangsu University Medical Education Cooperation Project","award":["JDYY2023085"],"award-info":[{"award-number":["JDYY2023085"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16047-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:55:00Z","timestamp":1776398100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a clinically applicable prediction tool for lymph node metastasis in papillary thyroid carcinoma using lasso-logistic regression"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anquan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"16047_CR1","doi-asserted-by":"crossref","unstructured":"Muntean C, Solomon A, Cipaian RC, et al. The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review. J Clin Med. 2025;14(2).","DOI":"10.3390\/jcm14020338"},{"key":"16047_CR2","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.2147\/JIR.S493397","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chang J, Hu B, Yang S. Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer. J Inflamm Res. 2024;17:8531\u201341.","journal-title":"J Inflamm Res"},{"key":"16047_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-024-01440-1","volume":"19","author":"H Sun","year":"2024","unstructured":"Sun H, Zhao X, Wang X, Ma J, Liu M. Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma. Diagn Pathol. 2024;19:13.","journal-title":"Diagn Pathol"},{"key":"16047_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12672-025-01807-w","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Tan AP, Zhong YS. Anti-cancer effect of midazolam via downregulating YWHAH in papillary thyroid cancer cells. Discov Oncol. 2025;16:72.","journal-title":"Discov Oncol"},{"key":"16047_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12672-025-01793-z","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Wang G, Chen D, Wu Z, Kei Y, Xu M. Combination of inflammatory proteins in serum can be used to diagnose papillary thyroid carcinoma with lymph node metastasis. Discov Oncol. 2025;16:51.","journal-title":"Discov Oncol"},{"key":"16047_CR6","doi-asserted-by":"publisher","first-page":"e0294594","DOI":"10.1371\/journal.pone.0294594","volume":"18","author":"WJ Song","year":"2023","unstructured":"Song WJ, Um IC, Kwon SR, Lee JH, Lim HW, Jeong YU, et al. Predictive factors of lymph node metastasis in papillary thyroid cancer. PLoS ONE. 2023;18:e0294594.","journal-title":"PLoS ONE"},{"key":"16047_CR7","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.2147\/IJGM.S487239","volume":"17","author":"T Zhang","year":"2024","unstructured":"Zhang T, Yuan B, Yu S. The Application of microRNAs in Papillary Thyroid Cancer: A Bibliometric and Visualized Analysis. Int J Gen Med. 2024;17:4681\u201399.","journal-title":"Int J Gen Med"},{"key":"16047_CR8","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3390\/curroncol30030200","volume":"30","author":"M Amanullah","year":"2023","unstructured":"Amanullah M, Pan M, Lu K, Pan X, Lu Y, Luo D, et al. Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid Cancer. Curr Oncol. 2023;30:2625\u201341.","journal-title":"Curr Oncol"},{"key":"16047_CR9","doi-asserted-by":"publisher","first-page":"1484838","DOI":"10.3389\/fendo.2024.1484838","volume":"15","author":"A Hu","year":"2024","unstructured":"Hu A, Tian J, Deng X, Wang Z, Li Y, Wang J, et al. The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively. Front Endocrinol (Lausanne). 2024;15:1484838.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12672-025-01755-5","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Hong K, Yao L, Shi D, Zhang J. Effect of long-stranded non-coding RNA-BANCR on the progression of thyroid papillary carcinoma and its mechanism. Discov Oncol. 2025;16:147.","journal-title":"Discov Oncol"},{"key":"16047_CR11","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.2147\/IJGM.S487992","volume":"17","author":"M Yu","year":"2024","unstructured":"Yu M, Deng J, Gu Y, Lai Y. Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter\u2009\u2264\u20091.0\u00a0cm. Int J Gen Med. 2024;17:4907\u201316.","journal-title":"Int J Gen Med"},{"key":"16047_CR12","doi-asserted-by":"publisher","first-page":"e31682","DOI":"10.1016\/j.heliyon.2024.e31682","volume":"10","author":"C Huang","year":"2024","unstructured":"Huang C, Ge Q, Wang Q, Ye L, Gong Y. Washout CYFRA 21\u2009\u2013\u20091: A tool to improve diagnostic accuracy of fine needle aspiration in the diagnosis of metastatic lymph nodes in papillary thyroid cancer. Heliyon. 2024;10:e31682.","journal-title":"Heliyon"},{"key":"16047_CR13","doi-asserted-by":"crossref","unstructured":"Heng Y, Yang Z, Cao P, Cheng X, Tao L. Lateral Involvement in Different Sized Papillary Thyroid Carcinomas Patients with Central Lymph Node Metastasis: A Multi-Center Analysis. J Clin Med. 2022;11(17).","DOI":"10.3390\/jcm11174975"},{"key":"16047_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bjorl.2020.05.004","volume":"88","author":"L Jiwang","year":"2022","unstructured":"Jiwang L, Yahong L, Kai L, Bo H, Yuejiao Z, Haotian W, et al. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study. Braz J Otorhinolaryngol. 2022;88:36\u201345.","journal-title":"Braz J Otorhinolaryngol"},{"key":"16047_CR15","doi-asserted-by":"publisher","first-page":"642142","DOI":"10.3389\/fonc.2021.642142","volume":"11","author":"S Xia","year":"2021","unstructured":"Xia S, Chen Y, Zhan W, Zhou W. Ultrasound-Guided Fine-Needle Aspiration Versus Fine-Needle Capillary Sampling in Evaluation of Lymph Node Metastasis of Thyroid Cancer. Front Oncol. 2021;11:642142.","journal-title":"Front Oncol"},{"key":"16047_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12957-019-1638-0","volume":"17","author":"K Kaliszewski","year":"2019","unstructured":"Kaliszewski K, Diakowska D, Wojtczak B, Forkasiewicz Z, Pupka D, Nowak \u0141, et al. Which papillary thyroid microcarcinoma should be treated as true cancer and which as precancer. World J Surg Oncol. 2019;17:91.","journal-title":"World J Surg Oncol"},{"key":"16047_CR17","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1038\/srep07748","volume":"5","author":"YR Hong","year":"2015","unstructured":"Hong YR, Yan CX, Mo GQ, Luo ZY, Zhang Y, Wang Y, et al. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci Rep. 2015;5:7748.","journal-title":"Sci Rep"},{"key":"16047_CR18","doi-asserted-by":"publisher","first-page":"580431","DOI":"10.3389\/fonc.2020.580431","volume":"10","author":"XW Bo","year":"2020","unstructured":"Bo XW, Lu F, Xu HX, Sun LP, Zhang K. Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma. Front Oncol. 2020;10:580431.","journal-title":"Front Oncol"},{"key":"16047_CR19","doi-asserted-by":"crossref","unstructured":"Al-Ibraheem A, Al-Shammaa M, Abdlkadir AS, Istatieh F, Al-Rasheed U, Pascual T, et al. Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective. Life (Basel). 2024;14(1).","DOI":"10.3390\/life14010158"},{"key":"16047_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10585-024-10285-3","volume":"41","author":"D Qiao","year":"2024","unstructured":"Qiao D, Deng X, Liang R, Li X, Zhang R, Lei Z, et al. Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma. Clin Exp Metastasis. 2024;41:613\u201326.","journal-title":"Clin Exp Metastasis"},{"key":"16047_CR21","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.acra.2022.09.002","volume":"30","author":"Y Peng","year":"2023","unstructured":"Peng Y, Zhang ZT, Wang TT, Wang Y, Li CH, Zuo MJ, et al. Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics. Acad Radiol. 2023;30:1400\u20137.","journal-title":"Acad Radiol"},{"key":"16047_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00423-024-03503-9","volume":"409","author":"Z Luo","year":"2024","unstructured":"Luo Z, Li W, Huo B, Li J. Nomogram predicts cervical lymph node metastasis of pathological subtypes of papillary thyroid carcinoma. Langenbecks Arch Surg. 2024;409:321.","journal-title":"Langenbecks Arch Surg"},{"key":"16047_CR23","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.eclinm.2024.102913","volume":"77","author":"F Hou","year":"2024","unstructured":"Hou F, Zhu Y, Zhao H, Cai H, Wang Y, Peng X, et al. Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter study. EClinicalMedicine. 2024;77:102913.","journal-title":"EClinicalMedicine"},{"key":"16047_CR24","doi-asserted-by":"crossref","unstructured":"Agyekum EA, Ren YZ, Wang X, Cranston SS, Wang YG, Wang J, et al. Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Clinical-Ultrasound Radiomic Machine Learning-Based Model. Cancers (Basel). 2022;14(21).","DOI":"10.3390\/cancers14215266"},{"key":"16047_CR25","doi-asserted-by":"publisher","first-page":"1287593","DOI":"10.3389\/fendo.2023.1287593","volume":"14","author":"J Lu","year":"2023","unstructured":"Lu J, Liao J, Chen Y, Li J, Huang X, Zhang H, et al. Risk factor analysis and prediction model for papillary thyroid carcinoma with lymph node metastasis. Front Endocrinol (Lausanne). 2023;14:1287593.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.7150\/ijms.95022","volume":"21","author":"W Jia","year":"2024","unstructured":"Jia W, Cai Y, Wang S, Wang J. Predictive value of an ultrasound-based radiomics model for central lymph node metastasis of papillary thyroid carcinoma. Int J Med Sci. 2024;21:1701\u20139.","journal-title":"Int J Med Sci"},{"key":"16047_CR27","doi-asserted-by":"publisher","first-page":"107327482412953","DOI":"10.1177\/10732748241295347","volume":"31","author":"H Chen","year":"2024","unstructured":"Chen H, Zhu L, Zhuang Y, Ye X, Chen F, Zeng J. Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Cancer Control. 2024;31:10732748241295347.","journal-title":"Cancer Control"},{"key":"16047_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","volume":"14","author":"FN Tessler","year":"2017","unstructured":"Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14:587\u201395.","journal-title":"J Am Coll Radiol"},{"key":"16047_CR29","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons K, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"key":"16047_CR30","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","volume":"28","author":"M van Smeden","year":"2019","unstructured":"van Smeden M, Moons KG, de Groot JA, Collins GS, Altman DG, Eijkemans MJ, et al. Sample size for binary logistic prediction models: Beyond events per variable criteria. Stat Methods Med Res. 2019;28:2455\u201374.","journal-title":"Stat Methods Med Res"},{"key":"16047_CR31","doi-asserted-by":"publisher","first-page":"11320","DOI":"10.21037\/qims-2025-1130","volume":"15","author":"W Yang","year":"2025","unstructured":"Yang W, Yue C, Su X, Chen Y, Chen W, Luo Y, et al. Preoperative multiparametric ultrasound for the prediction of central lymph node metastasis in papillary thyroid carcinoma. Quant Imaging Med Surg. 2025;15:11320\u201335.","journal-title":"Quant Imaging Med Surg"},{"key":"16047_CR32","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1089\/thy.2015.0130","volume":"25","author":"A Al Afif","year":"2015","unstructured":"Al Afif A, Williams BA, Rigby MH, Bullock MJ, Taylor SM, Trites J, et al. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Thyroid. 2015;25:1008\u201312.","journal-title":"Thyroid"},{"key":"16047_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/ajcp\/aqaa102","volume":"154","author":"JW Feng","year":"2020","unstructured":"Feng JW, Wu WX, Hu J, Hong LZ, Qin AC, Jiang Y, et al. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma. Am J Clin Pathol. 2020;154:848\u201358.","journal-title":"Am J Clin Pathol"},{"key":"16047_CR34","doi-asserted-by":"publisher","first-page":"1473858","DOI":"10.3389\/fonc.2024.1473858","volume":"14","author":"K Yu","year":"2024","unstructured":"Yu K, Wu X, Dai L, Le Q, Xie Y, Wang Y, et al. Risk factors associated with lymph node metastasis in papillary thyroid cancer: a retrospective analysis based on 2,428 cases. Front Oncol. 2024;14:1473858.","journal-title":"Front Oncol"},{"key":"16047_CR35","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2147\/IJGM.S461708","volume":"17","author":"Y Gu","year":"2024","unstructured":"Gu Y, Yu M, Deng J, Lai Y. The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma. Int J Gen Med. 2024;17:2887\u201397.","journal-title":"Int J Gen Med"},{"key":"16047_CR36","doi-asserted-by":"publisher","first-page":"205520762412332","DOI":"10.1177\/20552076241233244","volume":"10","author":"X Fan","year":"2024","unstructured":"Fan X, Zhang H, Wang Z, Zhang X, Qin S, Zhang J, et al. Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features. Digit Health. 2024;10:20552076241233244.","journal-title":"Digit Health"},{"key":"16047_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/a-2142-4811","volume":"55","author":"W Huang","year":"2023","unstructured":"Huang W, Chen D, Zhong M, Ye J, Zhi Z, Xiao Y, et al. Factors of Central Lymph Node Metastasis in Papillary Thyroid Cancer Based on C-TIRADS Analysis. Horm Metab Res. 2023;55:585\u201391.","journal-title":"Horm Metab Res"},{"key":"16047_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fendo.2020.00551","volume":"11","author":"F Medas","year":"2020","unstructured":"Medas F, Canu GL, Cappellacci F, Boi F, Lai ML, Erdas E, et al. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases. Front Endocrinol (Lausanne). 2020;11:551.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR39","doi-asserted-by":"crossref","unstructured":"Shangguan R, Kan G, Yang J, Bao L. Predicting papillary thyroid carcinoma cervical lymph node metastases: an algorithm using the American College of Radiology Thyroid Imaging, Reporting and Data System. Acta Radiol. 2023;64:101\u20137.","DOI":"10.1177\/02841851211069779"},{"key":"16047_CR40","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/02841851211041811","volume":"63","author":"JR Yang","year":"2022","unstructured":"Yang JR, Song Y, Chang SJ, Shi LL. Prediction of central compartment nodal metastases in papillary thyroid cancer using TI-RADS score, blood flow, and multifocality. Acta Radiol. 2022;63:1374\u201380.","journal-title":"Acta Radiol"},{"key":"16047_CR41","doi-asserted-by":"crossref","unstructured":"Shen H, Lv G, Li T, Wang Y, Chen K, Wang K, et al. Construction and Validation of a Predictive Nomogram Based on Ultrasound for Lymph Node Metastasis of Papillary Thyroid Carcinoma in the Cervical Central Region. Ultrasound Q. 2023;39:47\u201352.","DOI":"10.1097\/RUQ.0000000000000583"},{"key":"16047_CR42","doi-asserted-by":"publisher","first-page":"1392174","DOI":"10.3389\/fendo.2024.1392174","volume":"15","author":"S Wu","year":"2024","unstructured":"Wu S, Commentary. Meta-analysis of the effect and clinical significance of Delphian lymph node metastasis in papillary thyroid cancer. Front Endocrinol (Lausanne). 2024;15:1392174.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fendo.2020.00265","volume":"11","author":"J Mao","year":"2020","unstructured":"Mao J, Zhang Q, Zhang H, Zheng K, Wang R, Wang G. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:265.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR44","doi-asserted-by":"publisher","first-page":"772071","DOI":"10.3389\/fendo.2021.772071","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Lv H, Zhang S, Shi B, Sun Y. The Impact of Coexistent Hashimoto\u2019s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne). 2021;12:772071.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR45","doi-asserted-by":"publisher","first-page":"716728","DOI":"10.3389\/fendo.2021.716728","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Deng C, Shu X, Yu P, Wang H, Su X, et al. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1\u20132 Central Lymph Node Metastases. Front Endocrinol (Lausanne). 2021;12:716728.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12885-019-5835-6","volume":"19","author":"C Liu","year":"2019","unstructured":"Liu C, Xiao C, Chen J, Li X, Feng Z, Gao Q, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019;19:622.","journal-title":"BMC Cancer"},{"key":"16047_CR47","doi-asserted-by":"crossref","unstructured":"Wang Y, Zheng J, Hu X, Chang Q, Qiao Y, Yao X, et al. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis. Eur J Surg Oncol. 2023;49:560\u20137.","DOI":"10.1016\/j.ejso.2022.11.014"},{"key":"16047_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12885-021-09101-y","volume":"22","author":"C Chen","year":"2022","unstructured":"Chen C, Yi W, Zeng ZF, Wang QX, Jiang W, Gao YH, et al. Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery. BMC Cancer. 2022;22:7.","journal-title":"BMC Cancer"},{"key":"16047_CR49","doi-asserted-by":"publisher","first-page":"e1849","DOI":"10.1016\/j.urolonc.2018.11.010","volume":"37","author":"F Zhang","year":"2019","unstructured":"Zhang F, Xie Y, Ma X, Gu L, Li H, Li X, et al. Preoperative apolipoprotein B\/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma. Urol Oncol. 2019;37:e1849\u201318417.","journal-title":"Urol Oncol"},{"key":"16047_CR50","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000517735","volume":"44","author":"MM Liu","year":"2021","unstructured":"Liu MM, Chen ZH, Zhao LY, Zhao JY, Rong DL, Ma XK, et al. Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis. Oncol Res Treat. 2021;44:450\u201368.","journal-title":"Oncol Res Treat"},{"key":"16047_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12672-024-00877-6","volume":"15","author":"Z Lin","year":"2024","unstructured":"Lin Z, Ji X, Tian N, Gan Y, Ke L. APOB is a potential prognostic biomarker in hepatocellular carcinoma. Discov Oncol. 2024;15:28.","journal-title":"Discov Oncol"},{"key":"16047_CR52","doi-asserted-by":"publisher","first-page":"654689","DOI":"10.3389\/fonc.2021.654689","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu X, Chen D, Feng X, Hu J, Ge J, Yan C, et al. Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma. Front Oncol. 2021;11:654689.","journal-title":"Front Oncol"},{"key":"16047_CR53","doi-asserted-by":"publisher","first-page":"19044","DOI":"10.1038\/s41598-021-98513-8","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xu M, Huang H, Jiang X, Gong K, Liu Y, et al. Serum carcinoembryonic antigen elevation in benign lung diseases. Sci Rep. 2021;11:19044.","journal-title":"Sci Rep"},{"key":"16047_CR54","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1093\/rheumatology\/keaa819","volume":"60","author":"D Zhu","year":"2021","unstructured":"Zhu D, Qiao J, Tang S, Pan Y, Li S, Yang C, et al. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis. Rheumatology (Oxford). 2021;60:3896\u2013903.","journal-title":"Rheumatology (Oxford)"},{"key":"16047_CR55","doi-asserted-by":"publisher","first-page":"e7433","DOI":"10.7717\/peerj.7433","volume":"7","author":"J Wang","year":"2019","unstructured":"Wang J, Chu Y, Li J, Wang T, Sun L, Wang P, et al. The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer. PeerJ. 2019;7:e7433.","journal-title":"PeerJ"},{"key":"16047_CR56","doi-asserted-by":"publisher","first-page":"670594","DOI":"10.3389\/fcvm.2021.670594","volume":"8","author":"J Tang","year":"2021","unstructured":"Tang J, Ge QM, Huang R, Shu HY, Su T, Wu JL, et al. Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population. Front Cardiovasc Med. 2021;8:670594.","journal-title":"Front Cardiovasc Med"},{"key":"16047_CR57","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.29271\/jcpsp.2022.Supp2.S186","volume":"32","author":"C Ediz","year":"2022","unstructured":"Ediz C, Terzi NK, Akan S, Yilmaz O. Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male. J Coll Physicians Surg Pak. 2022;32:S186\u2013186188.","journal-title":"J Coll Physicians Surg Pak"},{"key":"16047_CR58","doi-asserted-by":"crossref","unstructured":"Niedzielska J, Jastrz\u0119bski T. Carcinoembryonic Antigen (CEA): Origin, Role in Oncology, and Concentrations in Serum and Peritoneal Fluid. J Clin Med. 2025;14(9).","DOI":"10.3390\/jcm14093189"},{"key":"16047_CR59","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1158\/0008-5472.CAN-10-1073","volume":"70","author":"Y Li","year":"2010","unstructured":"Li Y, Cao H, Jiao Z, Pakala SB, Sirigiri DN, Li W, et al. Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers. Cancer Res. 2010;70:8159\u201368.","journal-title":"Cancer Res"},{"key":"16047_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s43556-024-00181-3","volume":"5","author":"J Lei","year":"2024","unstructured":"Lei J, Wu L, Zhang N, Liu X, Zhang J, Kuang L, et al. Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1\u0251 axis. Mol Biomed. 2024;5:19.","journal-title":"Mol Biomed"},{"key":"16047_CR61","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1002\/1878-0261.12998","volume":"15","author":"Z Liang","year":"2021","unstructured":"Liang Z, Liu H, Zhang Y, Xiong L, Zeng Z, He X, et al. Cyr61 from adipose-derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin \u03b1V \u03b25. Mol Oncol. 2021;15:3447\u201367.","journal-title":"Mol Oncol"},{"key":"16047_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/cas.13437","volume":"109","author":"B Rizeq","year":"2018","unstructured":"Rizeq B, Zakaria Z, Ouhtit A. Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer Sci. 2018;109:33\u201342.","journal-title":"Cancer Sci"},{"key":"16047_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cncy.22694","volume":"131","author":"F Policardo","year":"2023","unstructured":"Policardo F, Tralongo P, Arciuolo D, Fiorentino V, Cardasciani L, Pierconti F, et al. p53 expression in cytology samples may represent a marker of early-stage cancer. Cancer Cytopathol. 2023;131:392\u2013401.","journal-title":"Cancer Cytopathol"},{"key":"16047_CR64","doi-asserted-by":"publisher","first-page":"1101410","DOI":"10.3389\/fendo.2023.1101410","volume":"14","author":"J Patel","year":"2023","unstructured":"Patel J, Klopper J, Cottrill EE. Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities. Front Endocrinol (Lausanne). 2023;14:1101410.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16047_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-022-03146-0","volume":"78","author":"C Pizzimenti","year":"2022","unstructured":"Pizzimenti C, Fiorentino V, Ieni A, Martini M, Tuccari G, Lentini M, et al. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine. 2022;78:1\u201312.","journal-title":"Endocrine"},{"key":"16047_CR66","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Epidemiology of Thyroid Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31:1284\u201397.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"16047_CR67","doi-asserted-by":"crossref","unstructured":"Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022;11(6).","DOI":"10.1530\/ETJ-22-0146"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16047-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:35:24Z","timestamp":1779856524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16047"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16047-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Medical Ethics Committee of Huzhou Central Hospital (approval number: 202207002-01). This research involved a retrospective analysis, and as it did not require patient recruitment or the collection of personal data, the informed consent requirement was waived by the Medical Ethics Committee of Huzhou Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}